1. Anti-angiogenesis maintenance therapy in newly diagnosed and relapsed ovarian cancer: a meta-analysis of phase III randomized controlled trials;Wang;Front. Pharmacol.,2021
2. Clinical significance of screening differential metabolites in ovarian cancer tissue and ascites by LC/MS;Liu;Front. Pharmacol.,2021
3. Identifying the effect of celastrol against ovarian cancer with network pharmacology and in vitro experiments;Wang;Front. Pharmacol.,2022
4. Epithelial ovarian cancer and the immune system: biology, interactions, challenges and potential advances for immunotherapy;Macpherson;J. Clin. Med.,2020
5. A multidisciplinary approach remains the best strategy to improve and strengthen the management of ovarian cancer;Falzone;Int. J. Oncol.,2021